This 60 minute training will cover:

  1. The Chapter 18A listing regime for pre-revenue biotech companies in Hong Kong
  2. Eligibility and suitability requirements for biotech listing applicants
  3. Core Product requirements and clinical trial milestones
  4. R&D focus, intellectual property and third-party investment criteria
  5. Market capitalisation, working capital and public float requirements
  6. Listing document disclosure obligations for biotech issuers
  7. Ongoing compliance and continuing obligations under Chapter 18A
  8. Practical insights from Exchange guidance and listing decisions

Course curriculum

    1. Video

    2. Presentation slides

    1. MC Quiz

    1. Evaluation form

About this course

  • 1 hour of video content

ABOUT THE INSTRUCTOR

Julia Charlton

Julia, a corporate finance lawyer, advises regulators, financial institutions and listed companies on the listing rules of both the Main Board of The Stock Exchange of Hong Kong Limited and GEM. She is experienced in the fields of securities law, capital markets, private equity, M&A, investment funds, restructuring and regulatory issues.
More about Julia

Important Information regarding availability of CPT/CPD points.

  1. Please note that our training programmes are not provided by an approved continuous professional trading (“CPT”) provider and may only be counted as CPT subject to internal compliance approval of your organisation (where applicable). According to the Guidelines on Continuous Professional Training issued by the Hong Kong Securities and Futures Commission (“SFC”), only training programmes relevant to the regulated activities in which an individual engages count towards CPT. Therefore, individuals are advised to select topics that are related to their regulated activities and will enhance their professionalism to satisfy their CPT requirements.
  2. The copyrights of all materials in our training programmes are owned by us. You shall not distribute, reproduce, share, transfer, copy or paste any or part of the materials provided to any other third party without prior written consent from us. In case of any of breach of copyrights, we will take legal action against you that you agree to indemnify us for any loss or damages.
  3. The access to internet and its reliability and stability and access to this online platform and the provision and availability of the training material can be subject to any internet control policy or media control of the relevant country or jurisdiction. In the circumstances where any access to the training material is restricted whereby the training cannot be provided, no refund will be arranged. If necessary, please pre-set or adjust any browsing device or software of your computer before the training.
  4. Our training programmes are for the exclusive use of authorised and/or paid users. We reserve all rights to take legal actions against any unauthorised or non-paying users or attendees for losses and damages and accordingly all the related certificates issued shall immediately be deemed null and void.
  5. Any provision of false, fraudulent or misleading information of attendance record may lead to cancellation of the completion certificate(s) issued and we reserve the right to notify any relevant regulator and law enforcement agency.
  6. The Stock Exchange of Hong Kong Limited (HKSE) has specified professional development requirements for listing company directors under Main Board Listing Rules 3.09F and 3.09G. The HKSE has stated that directors’ training must be of sufficient quality to adequately support directors’ development of their knowledge and expertise. Whilst we are of the view that our training materials provide relevant content for this purpose, their suitability to meet the HKSE’s requirements concerning HKSE listed company directors’ continuous professional development must be determined in each case by the relevant director and listed company concerned.
    Please note that we will not be liable if this training does not satisfy relevant CPT or CPD requirements.